Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52.7M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
221K
-
Shares change
-
+110K
-
Total reported value, excl. options
-
$379K
-
Value change
-
-$28.9K
-
Number of buys
-
8
-
Number of sells
-
-2
-
Price
-
$1.72
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q4 2018
14 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q4 2018.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 221K shares
of 52.7M outstanding shares and own 0.42% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (87.2K shares), RENAISSANCE TECHNOLOGIES LLC (68.8K shares), GEODE CAPITAL MANAGEMENT, LLC (22.2K shares), CITADEL ADVISORS LLC (13.7K shares), DIMENSIONAL FUND ADVISORS LP (13.3K shares), UBS Group AG (6.34K shares), BlackRock Inc. (4.83K shares), CITIGROUP INC (3.5K shares), BANK OF AMERICA CORP /DE/ (646 shares), and MORGAN STANLEY (536 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.